Detection of left ventricular hypertrophy by the R-wave voltage in lead aVL: population-based study

Sérgio Lamêgo Rodrigues1, Lílian Cláudia Souza Angelo, Marcelo Perim Baldo

  • 1Department of Physiological Sciences, Federal University of Espírito Santo, Av Marechal Campos 1468, Maruipe, Vitória, ES 29042-755, Brazil. sergiolamegor@gmail.com

Insights

The R-wave voltage in lead aVL (RaVL) effectively detects left ventricular hypertrophy (LVH) in the general population. This simple ECG measurement shows superior diagnostic ability compared to traditional criteria, making it a valuable screening tool.

Area of Science:

  • Cardiology
  • Medical Diagnostics
  • Public Health

Background:

  • Current hypertension guidelines recommend Sokolow-Lyon and Cornell voltage criteria for electrocardiogram (ECG) diagnosis of left ventricular hypertrophy (LVH).
  • Previous research suggests the R-wave voltage in lead aVL (RaVL) may be a simpler alternative for LVH detection in hypertensive patients.
  • The utility of RaVL in the general population, beyond hypertensive cohorts, requires further investigation.

Purpose of the Study:

  • To evaluate the diagnostic capability of RaVL for identifying echocardiographic left ventricular hypertrophy (ECHO-LVH) in a general urban population.
  • To compare the performance of RaVL against established ECG criteria (Sokolow-Lyon, Cornell) and other voltage measurements (SV3).
  • To determine if RaVL can serve as a practical screening tool for LVH in non-referral settings.

Main Methods:

  • A cohort of 682 participants (43.5% male, aged 27-72) from Vitoria, ES, Brazil, was enrolled.
  • Echocardiographic left ventricular hypertrophy (ECHO-LVH) was defined as LV mass >51 g/Ht(2.7).
  • The association between ECHO-LVH and ECG voltage measurements (Sokolow-Lyon, Cornell, SV3, RaVL) was analyzed.

Main Results:

  • RaVL demonstrated the strongest positive correlation with LV mass indexed to Ht(2.7), outperforming Cornell and Sokolow-Lyon criteria.
  • Receiver operating characteristic (ROC) curve analysis confirmed RaVL's superior performance in detecting ECHO-LVH compared to all other ECG measurements.
  • The S-wave voltage in lead V3 (SV3) showed no correlation with LV mass; Cornell's performance appears largely attributable to its RaVL component.

Conclusions:

  • The simple assessment of RaVL offers superior diagnostic ability for detecting ECHO-LVH in the general population.
  • RaVL's effectiveness positions it as a valuable and simple screening tool for left ventricular hypertrophy.
  • This finding supports the potential integration of RaVL into routine ECG assessments for broader population screening.
Abstract

Related Concept Videos

Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Assessment of apical radial pulse01:25

Assessment of apical radial pulse

Apical-Radial (A-R) Pulse Assessment
The A-R pulse assessment involves simultaneous evaluation of the apical and radial pulses. When the apical and radial pulse rates vary, this assessment helps identify a pulse deficit.
Pre-Procedural Preparation